In addition, we used the same PS-based methods to assess the association between IGF2 methylation and CRC prognosis using CRC patient PBLs and tumour tissues, and then further validated our findings using external datasets from EPIC-Italy CRC cohort and The Cancer Genome Atlas (TCGA) (17, 19). The gene discussed is IGF2; the disease is colorectal carcinoma.